论文部分内容阅读
目的:明确《中国药典》一部药材资源种类,为保障中药材质量和拓展利用中药资源提供思路。方法:统计分析2010年版《中国药典》一部药材和饮片,了解药典记载的中药材和饮片来源,归纳其中药资源特点。结果:2010年版《中国药典》一部正文所收载的616味中药,植物来源占87.66%,动物来源占8.28%,矿物来源占4.06%。结论:《中国药典》不仅是临床用药和制定中药质量标准的依据,还是中药资源开发与应用的依据,还要起到引导保护与合理利用野生药用动植物资源,促进中药产业可持续的作用。中药资源需要扩大来源,多基源多入药部位中药的质量需要进一步研究。
Objective: To clarify the types of medicinal materials in “Chinese Pharmacopoeia” and to provide ideas for ensuring the quality of Chinese medicinal materials and expanding the use of traditional Chinese medicine resources. Methods: Statistical analysis of 2010 edition of “Chinese Pharmacopoeia” a medicine and Pieces, understand the pharmacopoeia records of Chinese herbal medicines and Pieces source, summed up the characteristics of its traditional Chinese medicine resources. Results: 616 Chinese herbs contained in the body of a 2010 edition of “Chinese Pharmacopoeia” accounted for 87.66% of the total, with animal origin accounting for 8.28% and mineral origin accounting for 4.06%. Conclusion: “Chinese Pharmacopoeia” is not only the basis of clinical medication and quality standard of traditional Chinese medicine, but also the basis for the development and application of traditional Chinese medicine resources. It also plays a guiding role in guiding and protecting rational use of wild medicinal plants and animals resources and promoting the sustainable role of traditional Chinese medicine industry . The resources of traditional Chinese medicine need to be expanded, and the quality of traditional Chinese medicine with multiple sources and multiple medicinal ingredients needs to be further studied.